Secondary Versus Primary Stroke Prevention in Atrial Fibrillation: Insights From the Darlington Atrial Fibrillation Registry — Michał Mazurek (2017) | RDL Network
Secondary Versus Primary Stroke Prevention in Atrial Fibrillation: Insights From the Darlington Atrial Fibrillation Registry
Article 2017 en
Authors
MM
Michał Mazurek
ES
Eduard Shantsila
DL
Deirdre A. Lane
Abstract
1 min read
Only approximately half of eligible patients with AF are prescribed oral anticoagulation in line with guidelines. Guideline-adherent antithrombotic treatment significantly reduces the risk of stroke among primary prevention patients and both risk of recurrent stroke and death in patients with previous stroke.
Professor Gregory Lip, Cécile Laroche, Mircea I. Popescu, Lars Hvilsted Rasmussen, Laura Vitali Serdoz, Gheorghe‐Andrei Dan, Zbigniew Kalarus, Harry J.G.M. Crijns, Mário Oliveira, Luigi Tavazzi, Aldo Maggioni, Giuseppe Boriani
Eleni Korompoki, Peter U. Heuschmann, Kirsten Harvey, Cornelia Fießler, Uwe Malzahn, Klemens Hügen, Sabine Ullmann, Gabriele Putz Todd, Carolin Schuhmann, Joan Montaner, Igor Sibon, Stéphanie Debette, Christian Enzinger, Stefan Ropele, Viktoria Rücker, Kirsten Haas, Emily Harvey, Charles Wolfe, Yanzhong Wang, Peter Brønnum Nielsen, Valeria Caso, Professor Gregory Lip, Deirdre A. Lane, Omid Halse, Peter Ringleb, Walter E. Haefeli, Kathrin I. Foerster, Viktoria S. Wurmbach, Roland Veltkamp
Discussion(0)
No comments yet. Be the first to comment.